Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Unknown × oblimersen × Clear all

Phase

Phase NA 1 Phase 2/3 1 Phase 1 1

Status

Completed 7 Unknown 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Cyclophosphamide 36 fludarabine 27 Injections 27 Paclitaxel 22 Cisplatin 22 Gemcitabine 21 Radiotherapy 17 toripalimab 16 Carboplatin 15 Capecitabine 15 pembrolizumab 14 Fluorouracil 12 camrelizumab 10 apatinib 10 Temozolomide 10 Oxaliplatin 10 Cetuximab 10 Nivolumab 9 Drug Therapy 9 Docetaxel 9 Irinotecan 7 Indium 7 Bevacizumab 7 sintilimab 6 Vinorelbine 6 Peripheral Blood Stem Cell Transplantation 6 Lenalidomide 6 Ipilimumab 6 Interleukin-2 6 Immunotherapy, Adoptive 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00409383 2011-11-07

Abraxane and Temodar Plus Genasense in Advanced Melanoma

Genta Incorporated

Phase 1 Unknown

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡